降压药的作用是来自降压本身还是降压之外的靶器官保护?

被引：10

作者：

卢新政

李新立

机构：

[1] 南京医科大学第一附属医院心内科

来源：

中华高血压杂志 | 2006年 / 10期

关键词：

D O I：

10.16439/j.cnki.1673-7245.2006.10.002

中图分类号：

R544.1 [高血压];

学科分类号：

100201 [内科学];

摘要：

引用

收藏

页码：770 / 772

页数：3

相关论文

共 8 条

[1]

Blood pressure lowering for primary and secondary prevention of stroke [J].

Zhang, Haifeng ;

Thijs, Lutgarde ;

Staessen, Jan A. .

HYPERTENSION, 2006, 48 (02) :187-195

[2]

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients [J].

Liu, LS ;

Zhang, YQ ;

Liu, GZ ;

Li, W ;

Zhang, XZ ;

Zanchetti, A .

JOURNAL OF HYPERTENSION, 2005, 23 (12) :2157-2172

[3]

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial [J].

Julius, S ;

Kjeldsen, SE ;

Weber, M ;

Brunner, HR ;

Ekman, S ;

Hansson, L ;

Hua, TS ;

Laragh, J ;

McInnes, GT ;

Mitchell, L ;

Plat, F ;

Schork, A ;

Smith, B ;

Zanchetti, A .

LANCET, 2004, 363 (9426) :2022-2031

[4]

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003 [J].

Staessen, JA ;

Wang, JG ;

Thijs, L .

JOURNAL OF HYPERTENSION, 2003, 21 (06) :1055-1076

[5]

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease:: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) [J].

Fox, KM ;

Bertrand, M ;

Ferrari, R ;

Remme, WJ ;

Simoons, ML ;

Remme, WJ ;

Simoons, M ;

Bassand, JP ;

Aldershvile, J ;

Hildebrandt, P ;

Bertrand, M ;

Cokkinos, D ;

Toutouzas, P ;

Eha, J ;

Erhardt, L ;

Erikssen, J ;

Grybauskas, P ;

Kalnins, U ;

Karsch, K ;

Sechtem, U ;

Keltai, M ;

Klein, W ;

Lüscher, T ;

Mulcahy, D ;

Nieminen, M ;

Oto, A ;

Ozsaruhan, O ;

Paulus, W ;

Providencia, L ;

Riecansky, I ;

Ruzyllo, W ;

Ferrari, R ;

Santini, U ;

Tavazzi, L ;

Soler-Soler, J ;

Widimsky, P ;

Fox, KM ;

Julian, D ;

Dargie, H ;

Murray, G ;

Kübler, W ;

Thygesen, K ;

Duprez, D ;

Steg, G ;

Drexel, H ;

Gombotz, G ;

Klein, W ;

Duprez, D ;

Heyndrickx, GH ;

Legrand, V .

LANCET, 2003, 362 (9386) :782-788

[6]

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials [J].

Turnbull, F ;

Neal, B ;

Algert, C ;

Chalmers, J ;

Woodward, M ;

MacMahon, S ;

MacMahon, S ;

Baigent, C ;

Cutler, J ;

Fagard, R ;

Neal, B ;

Whelton, P ;

Yusuf, S ;

Algert, C ;

Chalmers, J ;

Chapman, N ;

MacMahon, S ;

Neal, B ;

Turnbull, F ;

Woodward, M ;

Agodoa, L ;

Baigent, C ;

Black, H ;

Boissel, JP ;

Brenner, B ;

Brown, M ;

Bulpitt, C ;

Byington, R ;

Chalmers, J ;

Collins, R ;

Cutler, J ;

Dahlof, B ;

Davis, B ;

Dens, J ;

Estacio, R ;

Fagard, R ;

Fox, K ;

Hansson, L ;

Holman, R ;

Hunsicker, L ;

Kostis, J ;

Kuramoto, K ;

Lewis, E ;

Lindholm, L ;

Lubsen, J ;

MacMahon, S ;

Malacco, E ;

Mancia, G ;

Neal, B ;

Pepine, C .

LANCET, 2003, 362 (9395) :1527-1535

[7]

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Lindholm, LH ;

Ibsen, H ;

Dahlöf, B ;

Devereux, RB ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Julius, S ;

Kjeldsen, SE ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H ;

Aurup, P ;

Edelman, J ;

Snapinn, S .

LANCET, 2002, 359 (9311) :1004-1010

[8]

Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension:: the Nordic Diltiazem (NORDIL) study [J].

Hansson, L ;

Hedner, T ;

Lund-Johansen, P ;

Kjeldsen, SE ;

Lindholm, LH ;

Syvertsen, JO ;

Lanke, J ;

de Faire, U ;

Dahlöf, B ;

Karlberg, BE .

LANCET, 2000, 356 (9227) :359-365